Nikki Kinloch, CEO of Cure Cancer, has announced that the organisation will be funding five new early-career researchers in 2023 to pursue their novel research
For the past 55 years, Cure Cancer has been dedicated to funding novel cancer research projects, giving talented early-career cancer researchers the opportunity to pursue
Neuroblastoma accounts for 15% of total childhood cancer deaths and sadly Glioblastoma has the worst survival rate of all cancers, with only 5% of children